Cornell Tech names Juliet Weissman chief administrative officer

Juliet Weissman, Cornell Tech’s new chief administrative officer, will oversee administrative, financial and operational aspects of Cornell Tech and will serve as a key advisor to Dean Dan Huttenlocher in these areas.

Greg Morrisett to return to Cornell as CIS dean

Greg Morrisett, the Allen B. Cutting Professor of Computer Science at Harvard University, has been named dean of Computing and Information Science. A former member of the Cornell faculty, he will assume his new post July 1.

Engineering grad programs rank in top 10 in U.S. News

Several graduate engineering fields at Cornell are in the top 10 in U.S. News and World Report’s 2016 "Best Graduate Schools" rankings, released March 10. Cornell Law School was ranked 13th overall and Johnson was ranked 16th.

Biomarker monitors testosterone therapy for osteoporosis

Researchers at Weill Cornell Medical College have discovered that a known biomarker of bone mineral density also can be used to monitor the effects of testosterone therapy in men who suffer from osteoporosis.

Scientists sequence genome of classical Hodgkin lymphoma

A team of researchers has sequenced the genome of classical Hodgkin lymphoma, illuminating exactly which proteins are altered in individual patients. The findings could pave the way to delivering personalized treatments.

Nobel laureate Harold Varmus to join Weill Cornell April 1

Dr. Harold Varmus, director of the National Cancer Institute at the National Institutes of Health, is internationally recognized for his research on retroviruses and the genetic basis of cancer.

Disease-carrying fleas abound on New York City's rats

Rats in New York City were found to carry a flea species capable of transmitting plague pathogens, according to a new study from a team of researchers from Cornell and Columbia.

Doctors nonsurgically correct infant ear deformities

A team of researchers at Weill Cornell has improved a nonsurgical procedure that safely and effectively corrects newborn ear deformities in just two weeks.

Weill Cornell brings innovative approach to TB research

With a new NIH grant, investigators in the Tuberculosis Research Unit hope to catalyze research findings made in the lab and at Weill Cornell's GHESKIO clinic in Haiti into new, effective agents to replace current TB therapies.